organ support should not delay the recovery from vein by modified haemodialysis blood lines. The arterio-venous pressure gradient moved the blood through injury of the native organ, or, as in some cases, of the transplanted organ.
the extracorporeal circuit and no pumps were utilized. Slow continuous production of ultrafiltrate was The fourth principle is that, particularly in the setting of multi-system organ failure, any organ replacement achieved, and substitution fluid was administered in post-dilutional mode to maintain the patient's fluid therapy should have absent or minimal proinflammatory effects.
balance. The technique subsequently was modified and newer options were made available. The use of a blood pump
The critically ill patient with a venous blood access became popular, and the arterio-venous treatments were partially abandoned. At the same time, the haemofilters were equipped with The typical features of MODS can be summarized as follows: the syndrome is one of the major cases of a second port in the ultrafiltrate compartment, thus permitting the countercurrent circulation of dialysate. death in intensive care; patients are on different life support systems, and monitoring, together with the In such cases, the treatment was named continuous haemodialysis or continuous haemodiafiltration. All maintenance of homeostatic parameters, becomes extremely complex.
these modifications are available today as routine treatments, and special machines have also been Vasoactive drugs are utilized to counterbalance haemodynamic instability or shock conditions; designed to facilitate the clinical application of these techniques ( Figure 1 ). mechanical ventilation or extracorporeal CO 2 removal are often required to sustain tissue oxygenation.
Recently we have utilized several of these new equipments both in haemofiltration and in haemodiafilCardiac support frequently is achieved not only with inotropic drugs but also with mechanical devices. ARF tration modes, using single-pass or even recirculation techniques. Sterile fluid bags are employed both as a is a common finding in this complex clinical picture. Finally, humoral and cellular mediators of inflamma-replacement solution and as a dialysate to be circulated countercurrent to blood flow in high-flux hollow fibre tion are generally present in tissues and systemic circulation at very high concentrations.
dialysers. The machines are equipped with a weighing system and pumps for the dialysate inlet and outlet Under such circumstances, an effective renal replacement therapy must provide adequate blood purification flow [29] [30] [31] [32] . Urea and creatinine, clearances as high as 60 l/24 h can be achieved with these systems. Larger from uraemic toxins, correction of fluid, electrolyte and acid-base disturbances, maintenance of the highest molecules are also cleared at high speed thanks to the high convective transport, and inulin clearances of up level of homeostasis, protection of the kidneys from further injury and, possibly, accelerated recovery of to 36 l/24 h have been obtained. Several companies have now undertaken to build newly conceived renal function after ARF.
machines, based on the principle that specifically designed equipment should be used in intensive care
Renal replacement strategies
patients as an alternative to classical, more sophisticated dialysis machines. The approach is a user friendly interface, beyond which the sophisticated complexity The clinical pattern and the history of patients affected by MODS have changed over the years. For a long of the machine is maintained with advanced functions.
Self-priming procedures and self-loading of the circuit time these patients were unable to survive more than a few hours, and renal replacement was not even are some of the new features that contribute to the simple use of the machine even by nurses who have instituted or only instituted at the last minute. Subsequently, with the advent of different life support not specialized in haemodialysis. systems, critically ill patients could be maintained at a sufficient level of stability to permit the institution of Efficiency of treatment renal replacement therapy. The outcome in these cases did not change significantly, and in some cases it apparently worsened. Of course, this was not the case, When continuous haemofiltration is utilized, solute clearance is equal to the amount of ultrafiltrate and the reason for this observation was that more seriously ill patients were treated with resuscitation obtained over 24 h. Assuming in CAVH a maximal clearance of 16 l, in a given patient with 100 mg/dl of procedures which were not available in the past. Therefore, a population of patients with higher severity blood urea nitrogen (BUN ), 16 g of urea nitrogen can be removed daily. When severely catabolic patients are indices is now treated with renal replacement therapies. In these cases, both haemo-and peritoneal dialysis involved, higher amounts of ultrafiltrate are needed to control azotaemia and, (CVVH ) frequently is used. In display some limitations and appear inadequate to treat such complicated patients.
such conditions, clearances of up to 30-40 l/24 h are required, and the use of a blood pump in the circuit In 1977, Kramer described a new treatment he named continuous arterio-venous haemofiltration permits the required level of efficiency to be obtained.
Urea is also effectively removed when a countercurrent (CAVH ) [5] . This treatment was based on a highly permeable haemofilter connected to an artery and a flow of dialysate is utilized in the circuit and diffusion is added to convection, thus obtaining a treatment pared with intermittent daily haemodialysis ( Figure 3) .
The explanation for this is the stable concentration defined as continuous arterio-venous haemodialysis (CAVHD) or continuous arterio-venous haemodia-profile of urea in blood during continuous therapies.
On the contrary, during intermittent haemodialysis, filtration (CAVHDF ). The first utilizes a low-flux membrane while the latter uses a synthetic high-flux the treatment is very efficient in the first hour but the amount of solute removal decreases significantly later membrane. As mentioned above, to avoid problems related to fluid control and to maintain the efficient on. In fact, despite a higher clearance being maintained, the solute concentration in blood is reduced and removal of small and large molecules, we now utilize a system derived from use in the chronic patient in the relevant amount of solute removal decreases.
Additionally, a remarkable rebound in concentration which filtration and backfiltration take place in a highly permeable dialyser during several hours of recir-after dialysis can be observed. culation of sterile bicarbonate dialysate ( Figure 2 ). The system is called continuous high-flux dialysis, and
Clinical aspects
allows the optimal use of dialysate fluid since the 10 l batch is discarded only when urea nitrogen has been equilibrated with the patient's blood levels. Clearances The complexity of the patient with ARF associated with multiple organ failure suggests that continuous of up to 60-70 l per day can be obtained for urea, while larger molecules can be cleared at a rate of therapies probably should be utilized as a first choice treatment in intensive care settings. 36-40 l per day. The weighing system of the machine allows for an accurate and precise fluid control in the Clinical conditions other than ARF, such as congestive heart failure, respiratory distress syndrome, cerebral patient. Despite a lower clearance, continuous therapies are more efficient at removing urea nitrogen com-oedema, etc., could also probably benefit from this Once the patient has reached the dry body weight, net filtration is minimal due to the mechanism of filtration and backfiltration occurring inside the hollow fibre dialyser. The two pumps placed on the dialysate compartment, and the gravimetric control, provide for an accurate fluid balance. The system can be used in single-pass or in recirculation mode.
form of treatment when olyguria is present or early of small volumes of ultrafiltration, a significant reduction in circulating blood volume can be observed in signs of renal insufficiency are associated.
The patient with severe haemodynamic instability intermittent treatments. This phenomenon is not observed in continuous treatments (Figure 4 ). This cannot be controlled with intermittent treatments such as haemodialysis or haemodiafiltration carried out for aspect may be of tremendous importance in the phase of recovery from ARF. The recovering kidney is 3-4 h per day. On the other hand, peritoneal dialysis can be inadequate to obtain the ultrafiltration volumes extremely sensitive to variations in perfusion pressure and blood flow. Accordingly, intermittent treatments and solute clearances necessary to control overhydration and severe catabolism. The slow continuous may be unphysiological and may contribute to possible further damage to the renal parenchyma. On the fluid removal achieved with continuous therapies such as CAVH/CVVH or CAVHD/CVVHD is generally contrary, continuous renal replacement therapies may be well tolerated and may contribute to a constant and well tolerated, and an optimal hydration status generally can be reached in a relatively short period of time progressive recovery of the kidney without major haemodynamic alterations. with adequate constancy of measured haemodynamic parameters. Direct measurements of haematocrit and These features present particular benefits for patients with severe cardiac contractility failure. Several mechblood volume during treatment, carried out with an optical red light absorption device (Crit-Line, anisms have been considered important in the amelioration of the haemodynamic conditions of patients Riverdale, UT ), demonstrated that even in presence After dialysis has mittent haemodialysis removes less urea nitrogen per week. The ceased, the patients experience a rapid inbound of bicarbonate, explanation lies in the stable concentration profile of urea nitrogen returning to a condition of definite acidosis. This has been shown during continuous therapy, compared with the yawning profile in to affect protein metabolism, albumin levels and enzyme function. intermittent treatments. Furthermore, patients on intermittent A stable correction of acidosis is reached in continuous haemofiltrahaemodialysis spend a remarkable number of hours per day with a tion due to a constant infusion of buffer via the replacement solution. higher degree of uraemic intoxication due to higher level of uraemic toxins.
haemodialysis produces a dramatic alkalinization during treatment and frequent observation of a subsequent rebound of acidosis (the same effect is seen for urea removal ), continuous therapies are slowly but continuously acting and reach a steady-state concentration both for uraemic solutes and organic acids in the blood ( Figure 5 ).
In patients with cerebral oedema, intermittent treatments may worsen the clinical condition because of a post-dialytic influx of fluid both in the grey and white matter. Since 1980, we have analysed the behaviour of brain density in patients undergoing different forms of renal replacement therapy. In chronic patients, brain density decreases after intermittent haemodialysis, with an influx of water in the tissue. This effect leads to a normalization of the brain tissue that shows a severe dehydration in the pre-dialytic phase [33, 34] . dialytic oedema. These alterations induced by intermittent treatments are not observed with continuous therapies that can therefore be utilized to maximal with congestive heart failure treated with continuous haemofiltration; the improvement of the ventricular advantage in these patients ( Figure 6 ).
Several mechanisms have been proposed to explain filling pressures, the reduction of the pre-load, the maintenance of the blood volume and the modulation the improvement of adult respiratory distress syndrome (ARDS ) patients treated with continuous haemofiltraof the renin-angiotensin axis, the reduction of afterload and the possible clearance of myocardial depressant tion. The continuous fluid withdrawal from the interstitium due to a progressive vascular refilling represents substances. Another factor considered important has been the possibility of a dissociation of sodium and a major advantage. However, the modulation of the vascular inflammation thanks to the clearance or water transport during haemofiltration techniques. This, together with the isotonic characteristics of the adsorption of specific proinflammatory substance onto the membrane recently has been hypothesized. This ultrafiltrate, may lead to a continuous vascular refilling and an improved haemodynamic condition. mechanism has also be invoked as an interesting possibility for patients with systemic immunoresponse Continuous therapies can also effectively correct various forms of acidosis. In fact, while intermittent syndrome (SIRS) or septic shock. multiple organ dysfunction raises the possibility that removal of these cytokines from the circulation of clinically ill patients may be of benefit. In recent studies, CVVH was shown to remove significant amounts of proinflammatory mediators. We have found clearances ( l/day) of 30.7 and 36.1 for TNF-a and IL-1b, with a total excretion rate (ng/day) of 14.1 and 1.06 [35] . Excretion was mainly by ultrafiltrate, although in other studies we have also demonstrated significant absorption capacity of cytokines and autacoids by hydrophobic membranes [36 ] .
However, several aspects might need to be clarified before the extracorporeal removal of cytokines is unanimously accepted as clinically relevant. Possible advancements in the extracorporeal therapies dedicated to critically ill patients should take into account the 
Conclusions The concept of renal support
While isolated ARF can be treated advantageously with standard intermittent treatments, continuous renal The current era of critical care practice has witnessed the evolution of challenging new trends. Today, serious replacement therapies appear to be the appropriate treatment in patients with ARF complicated by different manifestations may arise in transplanted patients due to surgical or medical complications, immunosuppres-clinical problems. In patients with ARF and other organ system failure, continuous treatments appear to be the sive therapy and renal failure. A clinically important infection or acute sepsis may occur in these patients, only possibility for obtaining positive results from an extracorporeal therapy. Finally, if adequate modulation alone or as a major complication of ARF.
Roughly 50% of such infections are caused by of chemical mediators of the septic syndrome could be achieved with these treatments, the whole concept of Gram-negative bacteria and, of these cases, 10-20%, may result in a documented period of bacteraemia, 'renal protection' or 'renal support' would be exploited and a real possibility of preventing or shortening ARF with attendant haemodynamic instability and organ dysfunction. High mortality rates are reported for such would probably be in our hands. There is no question, however, that continuous therapies seem to meet the severe pathological conditions. The magnitude of this problem has made sepsis and its treatment a prominent criteria for adequacy we proposed in the introduction.
Such treatments should be provided to all patients in public and scientific issue. Sepsis frequently is associated with Gram-negative infection. Bacterial lipopoly-which standard therapies represent less benefits or even a potential hazard. saccharides (LPSS), released from Gram-negative cell walls, possess a wide range of biological activities, and appear to be the main causative factors in sepsis-
